Screening of TMA Patients für ADAMTS13 Activity (Adamscreen) (Adamscreen)
Screening of TMA Patients for ADAMTS13 Activity and the Description of Systematic Organ Damage and/or Organ Failure in Different Entities of Thrombotic Microangiopathies (TMA)
Sponsor: University of Cologne
This observational or N/A phase trial investigates Thrombotic Microangiopathies and is currently ongoing. University of Cologne leads this study, which shows 11 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
▶ Show 6 earlier versions
-
Mar 2019 — Nov 2020 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Jun 2018 — Mar 2019 [monthly]
Not Yet Recruiting
-
May 2018 — Jun 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — May 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Not Yet Recruiting NA
First recorded
Mar 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Cologne
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.